In summary, our study concluded that miR-1 can regulate ECM adhesion function, activate the PI3K/Akt signaling pathway to inhibit p21/p27 expression, and lead to the upregulation of CDK1 by affecting FAK, ultimately prompting NPC tumorigenesis and progression. This evidence concerns the gene CDK1 and nasopharyngeal carcinoma.